Exact Mass: 385.003

Exact Mass Matches: 385.003

Found 50 metabolites which its exact mass value is equals to given mass value 385.003, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cefaclor hydrate

Cefaclor Monohydrate

C15H16ClN3O5S (385.0499)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Indisulam

Indisulam

C14H12ClN3O4S2 (384.9958)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor D004791 - Enzyme Inhibitors > D002257 - Carbonic Anhydrase Inhibitors C471 - Enzyme Inhibitor > C29577 - Carbonic Anhydrase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents

   

4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate

4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate

C17H11N3O6S (385.0369)


   

(-)-Epigallocatechin sulfate

(2S,3S)-8-Hydroxy-3-(sulphooxy)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-6-olic acid

C15H13O10S- (385.0229)


Epigallocatechin sulfate is the sulfated form of epigallocatechin, wherein the sulfate group is attached to the O-3 position. Sulfation is a phase II biotransformation reaction that involves a sulfotransferase enzyme catalyzing the transfer of a sulfo group from a donor cosubstrate, usually 3-phosphoadenosine-5-phosphosulfate (PAPS), to a substrate molecules hydroxyl group (in this case epigallogatechin). Sulfation is involved in a variety of biological processes, including detoxification, hormone regulation, molecular recognition, cell signaling, and viral entry into cells. Epigallocatechin (EGC) is a flavan-3-ol, which are derivatives of flavans that possess a 2-phenyl-3,4-dihydro-2H-chromen-3-ol skeleton. EGC is one of the antioxidant chemicals found in many fruits and teas. This compound possesses an epimer, found notably in green tea, called "gallocatechin" (GC) (PMID: 30917581), with the gallate residue being in an isomeric trans position. Other sources of gallocatechin are bananas, persimmon, and pomegranate. This compound had been shown to have moderate affinity to the human cannabinoid receptor, which may contribute to the health benefits found by consuming green tea.

   

N-(1-Pyrenyl)iodoacetamide

2-IODO-N-(PYREN-1-YL)ACETAMIDE

C18H12INO (384.9964)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D009676 - Noxae > D000477 - Alkylating Agents > D007461 - Iodoacetates D004396 - Coloring Agents > D005456 - Fluorescent Dyes

   

Indisulam

N-(3-Chloro-1H-indol-7-yl)-4-sulphamoylbenzenesulphonamide

C14H12ClN3O4S2 (384.9958)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor D004791 - Enzyme Inhibitors > D002257 - Carbonic Anhydrase Inhibitors C471 - Enzyme Inhibitor > C29577 - Carbonic Anhydrase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents

   

Mavacoxib

4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide

C16H11F4N3O2S (385.0508)


   
   

(+)-6R-discorhabdin Y

(+)-6R-discorhabdin Y

C18H16BrN3O2 (385.0426)


   

OXODIPEROXY(PYRIDINE)(1,3-DIMETHYL-3,4,5,6-TETRAHYDRO-2(1H)-PYRIMIDINONE)MOLYBDENUM (IV)

OXODIPEROXY(PYRIDINE)(1,3-DIMETHYL-3,4,5,6-TETRAHYDRO-2(1H)-PYRIMIDINONE)MOLYBDENUM (IV)

C11H17MoN3O6 (385.0171)


   

Methyl (2S)-(2-chlorophenyl){[(4-nitrophenyl)sulfonyl]oxy}acetate

Methyl (2S)-(2-chlorophenyl){[(4-nitrophenyl)sulfonyl]oxy}acetate

C15H12ClNO7S (385.0023)


   

2,2,3-tris(4-chlorophenyl)propiononitrile

2,2,3-tris(4-chlorophenyl)propiononitrile

C21H14Cl3N (385.0192)


   

6-BROMO-2-(3-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

6-BROMO-2-(3-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

C19H16BrNO3 (385.0313)


   

6-BROMO-2-(2-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

6-BROMO-2-(2-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

C19H16BrNO3 (385.0313)


   

6-BROMO-2-(4-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

6-BROMO-2-(4-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

C19H16BrNO3 (385.0313)


   

Bis(ethylenediamine)platinum(II) chloride

Bis(ethylenediamine)platinum(II) chloride

C4H16Cl2N4Pt (385.04)


   

ethyl 2-piperazine-4-(3,5-dichloro)phenyl thiazole-5-carboxylate

ethyl 2-piperazine-4-(3,5-dichloro)phenyl thiazole-5-carboxylate

C16H17Cl2N3O2S (385.0418)


   

(2-AMINO-2-METHYL-PROPYL)-UREA

(2-AMINO-2-METHYL-PROPYL)-UREA

C18H18Cl3NO2 (385.0403)


   

METHYL 2-(2,4-DICHLORO-5-FLUOROBENZOYL)-3-((4-FLUOROPHENYL)AMINO)ACRYLATE

METHYL 2-(2,4-DICHLORO-5-FLUOROBENZOYL)-3-((4-FLUOROPHENYL)AMINO)ACRYLATE

C17H11Cl2F2NO3 (385.0084)


   

2-(4-Bromophenyl)-4,6-diphenylpyridine

2-(4-Bromophenyl)-4,6-diphenylpyridine

C23H16BrN (385.0466)


   

3-AMINO-5-HYDROXY-PENTEN-1

3-AMINO-5-HYDROXY-PENTEN-1

C18H18Cl3NO2 (385.0403)


   

5-bromo-6-chloro-3-indoxyl nonanoate

5-bromo-6-chloro-3-indoxyl nonanoate

C17H21BrClNO2 (385.0444)


   
   

N-{3-Chloro-4-[(2-chlorobenzoyl)amino]phenyl}-2-pyridinecarboxami de

N-[3-chloro-4-[[(2-chlorophenyl)-oxomethyl]amino]phenyl]-2-pyridinecarboxamide

C19H13Cl2N3O2 (385.0385)


   

(Ferrocenylmethyl)trimethylammonium Iodide

(Ferrocenylmethyl)trimethylammonium Iodide

C14H20FeIN (384.999)


   

Arsonic acid,[4-[[4-(dimethylamino)phenyl]azo]phenyl]-, monohydrochloride (9CI)

Arsonic acid,[4-[[4-(dimethylamino)phenyl]azo]phenyl]-, monohydrochloride (9CI)

C14H17AsClN3O3 (385.0174)


   

Polyadenylic acid potassium salt

Polyadenylic acid potassium salt

C10H13KN5O7P (385.019)


   

4-Bromo-N-cyclohexyl-3-(trifluoromethyl)benzenesulfonamide

4-Bromo-N-cyclohexyl-3-(trifluoromethyl)benzenesulfonamide

C13H15BrF3NO2S (384.9959)


   

(5-bromo-4-chloro-1H-indol-3-yl) nonanoate

(5-bromo-4-chloro-1H-indol-3-yl) nonanoate

C17H21BrClNO2 (385.0444)


   

4-(4-Bromo-1H-pyrazol-1-yl)-N,N-diisopropylbenzenesulfonamide

4-(4-Bromo-1H-pyrazol-1-yl)-N,N-diisopropylbenzenesulfonamide

C15H20BrN3O2S (385.046)


   

copper(ii) benzoylacetonate

copper(ii) benzoylacetonate

C20H18CuO4 (385.0501)


   

Mavacoxib

Mavacoxib

C16H11F4N3O2S (385.0508)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor

   

5-[1-(4-Fluorophenyl)sulfonyl-3-pyrazolyl]-2-phenylthiazole

5-[1-(4-Fluorophenyl)sulfonyl-3-pyrazolyl]-2-phenylthiazole

C18H12FN3O2S2 (385.0355)


   
   

ethyl 1-[4-(2-fluorophenyl)-1,3-thiazol-2-yl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate

ethyl 1-[4-(2-fluorophenyl)-1,3-thiazol-2-yl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate

C16H11F4N3O2S (385.0508)


   

n-Ethyl-n-[(nonafluorobutyl)sulfonyl]glycine

n-Ethyl-n-[(nonafluorobutyl)sulfonyl]glycine

C8H8F9NO4S (385.003)


   

dUDP trianion

dUDP trianion

C9H11N2O11P2-3 (384.9838)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

(2S)-2-ammonio-5-{[(2R)-1-[(carboxylatomethyl)amino]-1-oxo-3-(selanylsulfanyl)propan-2-yl]amino}-5-oxopentanoate

(2S)-2-ammonio-5-{[(2R)-1-[(carboxylatomethyl)amino]-1-oxo-3-(selanylsulfanyl)propan-2-yl]amino}-5-oxopentanoate

C10H15N3O6SSe- (384.9847)


   
   

[(2R,3S,4R,5S)-5-{2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl}-3,4-dihydroxyoxolan-2-yl]methyl phosphate

[(2R,3S,4R,5S)-5-{2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl}-3,4-dihydroxyoxolan-2-yl]methyl phosphate

C12H12N5O8P-2 (385.0423)


   
   

N-[4-oxo-5-(2-oxo-1H-indol-3-ylidene)-2-thiazolyl]benzenesulfonamide

N-[4-oxo-5-(2-oxo-1H-indol-3-ylidene)-2-thiazolyl]benzenesulfonamide

C17H11N3O4S2 (385.0191)


   

3-chloro-N-[3-nitro-5-(2-pyridinylthio)phenyl]benzamide

3-chloro-N-[3-nitro-5-(2-pyridinylthio)phenyl]benzamide

C18H12ClN3O3S (385.0288)


   

4-chloro-3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide

4-chloro-3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide

C15H16ClN3O3S2 (385.0322)


   

N-(4-bromo-5-methyl-2-oxo-3-indolyl)-3-phenylpropanehydrazide

N-(4-bromo-5-methyl-2-oxo-3-indolyl)-3-phenylpropanehydrazide

C18H16BrN3O2 (385.0426)


   

N-[4-bromo-3-(trifluoromethyl)phenyl]-2,4,6-trimethylbenzamide

N-[4-bromo-3-(trifluoromethyl)phenyl]-2,4,6-trimethylbenzamide

C17H15BrF3NO (385.0289)


   

5-Bromo-2-furancarboxylic acid (3-benzamidophenyl) ester

5-Bromo-2-furancarboxylic acid (3-benzamidophenyl) ester

C18H12BrNO4 (384.995)


   

dUDP(3-)

dUDP(3-)

C9H11N2O11P2 (384.9838)


A 2-deoxyribonucleoside 5-diphosphate obtained by deprotonation of the diphosphate OH groups of 2-deoxyuridine 5-diphosphate (dUDP).

   

Cytidine 5'-phosphate 2',3'-cyclic phosphate

Cytidine 5'-phosphate 2',3'-cyclic phosphate

C9H13N3O10P2 (385.0076)


   

GLUT4-IN-2

GLUT4-IN-2

C17H11N3O4S2 (385.0191)


GLUT4-IN-2 is a potent and selective GLUT4 inhibitor with IC50s of 11.4 μM and 6.8 μM for GLUT1 and GLUT4, respectively. GLUT4-IN-2 induces cell apoptosis and cell cycle arrest at G0/G1phase. GLUT4-IN-2 shows potent antitumor activity[1].